Top Banner

of 13

Part06 Ch14 Copy

Jul 06, 2018

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/16/2019 Part06 Ch14 Copy

    1/13

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM MESENTERIC REVASCULARIZATION PROCEDURES — 1

    DOI 10.2310/7800.2109

    11/11

    MESENTERIC REVASCULARIZA-TION PROCEDURES

    Ravi Dhanisetty, MD, Scott Musicant, MD, Lloyd M. Taylor, Jr, MD, FACS, and Gregory L. Moneta, MD

    artery stenosis associated with chronic mesenteric ischemia.3,4 

    Although it is a technically difficult examination to perform,

    in experienced hands, the sensitivity of duplex scanning for

    detecting lesions in the superior mesenteric artery (SMA) and

    celiac artery is 92% and 87%, respectively. When compared

    with catheter-based angiography, the overall accuracy for

    detection of a 70% lesion in the SMA and celiac artery

    was 96% and 82%, respectively.5 By itself, however, duplex

    scanning is not sufficient for planning a mesenteric revascu-

    larization procedure.

    Multidetector CT angiography is the most frequently used

    technique for the diagnosis of mesenteric artery stenosis or

    occlusions consistent with mesenteric ischemia. Multidetec-

    tor CT angiography has in many cases replaced other modal-

    ities as the imaging study of choice for evaluation of chronic

    mesenteric ischemia [see Figure 2]. It can accurately identifysignificant stenosis in the celiac artery and SMA, identify

    significant visceral collaterals, and exclude other potential

    intra-abdominal processes.6,7 CT angiography has higher spa-

    tial resolution and allows for assessment of visceral branches,

    including the inferior mesenteric artery, with greater accuracy

    than contrast-enhanced magnetic resonance angiography.8,9 

    Mesenteric ischemia is encountered infrequently. To date,

    there have been no randomized, controlled trials comparing

    treatment modalities for either acute or chronic mesenteric

    ischemia. Consequently, decisions on how to treat this con-

    dition must be based on a few large case series in which a

    variety of procedures were used.

    Overall evaluation and management of acute mesenteric

    ischemia are addressed more fully elsewhere. In what follows,

    we focus specifically on the operative techniques used to treat

    mesenteric ischemia (whether chronic or acute) and discuss

    the available literature supporting their use. The appropriate

    technique for a particular patient varies according to the

    individual anatomy and intraoperative findings. The relevant

    surgical procedures may be conveniently divided into those

    employed for chronic mesenteric ischemia and those employed

    for acute ischemia.

    Procedures for Chronic Intestinal Ischemia

     

    In 1936, J. E. Dunphy was the first to suggest that timely

    diagnosis and intervention for mesenteric artery occlusive

    disease may prevent intestinal infarction.1 It is now clear that

    optimal treatment of mesenteric ischemia depends on prompt

    diagnosis and that a high index of suspicion is vital.

    Patients with chronic intestinal ischemia generally, but not

    always, report experiencing colicky, dull, or aching abdomi-

    nal pain, primarily located in the epigastrium but occasionally

    radiating to the back. Symptoms typically begin 15 to 30

    minutes after eating and may last as long as 3 to 4 hours.

    Peritonitis is not a characteristic of reversible intestinal isch-

    emia; rather, it is indicative of intestinal infarction. Chronic

    postprandial abdominal symptoms result in markedly reduced

    food intake (so-called food fear),2  which generally leads to

    weight loss.

    Physical examination often yields no significant abdominal

    findings. Abdominal bruits may be audible but are a non-

    specific finding. Patients often, but not always, show evidence

    of atherosclerotic disease in other vascular territories. Bowel

    habits vary, ranging from normal elimination to diarrhea or

    constipation.

    Mesenteric ischemia is a clinical diagnosis. Imaging studies

    are therefore used to confirm mesenteric artery stenosis orocclusion, supportive of a diagnosis of mesenteric ischemia.

    Useful imaging modalities include duplex ultrasonography,

    contrast angiography, multi-detector computed tomographic

    (CT) angiography, and magnetic resonance angiography.

    Duplex scanning is effective in detecting visceral artery steno-

    sis [see Figure 1] and may allow earlier detection of visceral

    Figure 1 Example of a duplex spectral waveform with

    comparative arteriography in a patient with superior

    mesenteric artery (SMA) stenosis. The peak systolic

    velocity (> 550 cm/s) is dramatically increased over normal

    (< 275 cm/s).

     American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    2/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 2

    11/11

    dangerous. Appropriate magnification views generally allow

    characterization of the proximal SMA beyond its origin, even

    without selective catheterization of the SMA. Intra-arterial

    digital subtraction techniques are usually adequate for lateral

    views and require less contrast material than other techniques.

    Arteriography also demonstrates coexisting lesions of the

    aorta and of the renal and iliac arteries that may be important

    in planning revascularization.

     

    Essentially all patients with peripheral artery disease have

    some degree of concomitant coronary artery disease (CAD).

    Although no symptoms of CAD may be evident, care must

    still be taken to provide perioperative cardiac protection.

    Perioperative beta blockade, antiplatelet therapy, and statin

    medications should be routinely employed whenever possible

    in patients undergoing elective arterial reconstructive

    procedures.

    If the patient is undergoing a bypass procedure, the choice

    of graft material should be addressed. In general, prosthetic

    grafts work well for mesenteric artery bypasses. However, the

    entire abdomen and both legs should still be included in the

    operative field in case autologous vein proves necessaryfor the bypass conduit. Autologous vein is often required in

    cases involving bowel resection and may also be preferable

    for bypasses to smaller visceral vessels. If an autologous vein

    bypass procedure is planned, preoperative duplex scanning of

    the greater saphenous and femoral veins is recommended to

    facilitate selection of the best available vein for the conduit.

    Together with noncontrast images, CT, in many cases, offers

    enough anatomic details to plan open procedures. Limita-

    tions include contrast-related nephropathy, hypersensitivity

    reactions, and inaccurate timing of contrast infusion that may

    lead to an indeterminate study and delayed diagnosis.

    Arteriography is the traditional imaging technique employed

    in planning mesenteric revascularization for chronic intestinal

    ischemia [see Figure 3 and Figure 4]. Lateral and anteroposte-

    rior views of the aorta are required for full evaluation of the

    severity of visceral stenosis or occlusion and the extent of col-

    lateral development. In most cases, a transfemoral Seldinger

    technique is suitable, although in the setting of iliofemoral

    occlusive disease, a transaxillary approach is occasionallyrequired. Between 60 and 100 mL of contrast material is

    required for appropriate lateral and anteroposterior views of

    the abdominal aorta. Visceral artery lesions are usually ostial

    but may extend beyond the orifice of the vessel as a posterior

    plaque, especially in the SMA. Selective catheterization of

    the main intestinal arteries is rarely necessary and may be

    Figure 2 Computed tomographic angiography is being used

    more frequently to demonstrate mesenteric artery lesions.

    With three-dimensional reconstruction, segmental stenosis

    or occlusions can be demonstrated in mesenteric arteries.

    Above is an example of proximal occlusion (arrow) of the

    superior mesenteric artery with distal reconstitution via

    collaterals.

    Figure 3 A lateral aortogram clearly shows severe stenosis

    of the superior mesenteric artery (arrow) in a patient with

    intestinal ischemia.

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    3/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 3

    11/11

     

    Visceral Endarterectomy

    Visceral endarterectomy for treatment of mesenteric isch-

    emia was first described in 1958 by Shaw and Maynard,10 

    who performed endarterectomy of the SMA in a blind,

    retrograde fashion through a distal arteriotomy. At present,

    retrograde endarterectomy cannot be recommended.

    The SMA can be approached directly once control of the

    supraceliac aorta has been obtained.11 A longitudinal incision

    is made across the origin of the SMA, and an endarterectomy

    is performed. In most patients, the exposure is limited.

    This direct approach may be considered when the SMA is

    widely separated from the renal arteries and the visceral

    aorta is relatively free of disease; however, this scenario is

    uncommon.A more versatile endarterectomy technique is transaortic

    endarterectomy.12  This procedure involves a posterolateral

    approach to the aorta, in which the aorta is exposed trans-

    peritoneally with medial visceral rotation. Alternatively, a

    completely retroperitoneal approach may be taken. The main

    disadvantage of the retroperitoneal approach is that it restricts

    the surgeon’s ability to assess the bowel at the completion of

    revascularization.

    Transaortic endarterectomy Step 1: incision and initial

    approach  A midline incision is recommended. A complete

    medial visceral rotation is performed, with the left kidney left

    in its bed.

    Step 2: exposure  The lateral aorta is exposed, and theceliac artery and the SMA may be identified anteriorly; the

    left renal artery lies posteriorly.

    Step 3: endarterectomy  A trapdoor incision is made in the

    aortic wall in such a way as to encompass the orifices of the

    SMA and the celiac artery. Partial occlusion of the aorta with

    a clamp is sometimes possible, but in most cases, complete

    aortic occlusion is required. If necessary, the aortotomy can

    be extended distally and posteriorly to include the renal artery

    orifices as well.

    Among the advantages of this operation are that it permits

    simultaneous endarterectomy of the aorta and all visceral

    vessel orifices and that it does not require the use of

    prosthetic material [see Figure 4]. The disadvantages include

    the potential risks associated with suprarenal clamping (e.g.,

    cardiac overload, renal and lower extremity embolization,

    and ischemia). Because of these risks, the need for more

    extensive dissection, and the unfamiliarity of most surgeons

    with this procedure, arterial bypass procedures are generally

    preferred for treatment of chronic mesenteric ischemia.

     Mesenteric Arterial Bypass

    Technical considerations Single-vessel versus multiple-

    vessel revascularization  There are two schools of thought

    on the extent of revascularization for chronic mesenteric

    ischemia. Proponents of so-called complete revascularization

    advocate revascularization of both the celiac artery and the

    SMA and suggest that this approach makes recurrent isch-

    emia less likely should one graft or graft limb undergo throm-

    bosis.13  In a 1992 study, overall graft patency and survival

    were better in patients who underwent multiple-vessel bypassthan in those who underwent single-vessel bypass. The inves-

    tigators concluded that multiple-vessel bypass patients were

    likely to remain asymptomatic because of the presence of

    additional grafts or graft limbs that remained patent.13

    Others maintain that the critical vessel involved in chronic

    mesenteric ischemia is the SMA and argue that bypass to

    the SMA alone is a relatively simple procedure that relieves

    symptoms of mesenteric ischemia. In a 2000 study evaluating

    49 patients who underwent bypass to the SMA alone, the

    9-year primary assisted graft patency rate was 79% and the

    5-year survival rate was 61%14 —results equivalent to those

    noted in contemporary studies of multiple-vessel revascular-

    ization for chronic intestinal ischemia.15

     Antegrade versus retrograde bypass  Mesenteric bypass grafts

    may originate either above or below the renal arteries. Bypassgrafts are considered antegrade if they originate on the ante-

    rior surface of the abdominal aorta cephalad to the celiac

    artery and retrograde if they originate from the infrarenal

    aorta or a common iliac artery. The distal thoracic aorta can

    also serve as an inflow site for antegrade mesenteric bypass.

    Antegrade bypass from the supraceliac aorta, using either

    Figure 4 Lateral aortogram showing so-called coral reef

    atheroma involving the visceral aorta with occlusion of the

    origin of the superior mesenteric artery. A patient with

    mesenteric ischemia and this angiogram may be best treated

    with transaortic endarterectomy.

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    4/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 4

    11/11

    prosthetic material or autologous vein, has certain advan-

    tages, including a straight graft configuration that minimizes

    turbulence and graft kinking. Typically, there is also reduced

    atherosclerotic calcification in the supraceliac aorta.16  The

    disadvantages of antegrade bypass are similar to those of

    visceral endarterectomy and derive from the need to clamp

    the supraceliac aorta for the proximal anastomosis. As with

    visceral endarterectomy, partial occlusion clamping is theo-

    retically possible but not always practical. Clamping of the

    supraceliac aorta may increase the risk of cardiac events,

    visceral or renal emboli, and ischemia. One prerequisite for

    use of the supraceliac aorta in an antegrade bypass is that the

    vessel must be angiographically normal to ensure that it can

    safely be clamped. It should also be kept in mind that reop-

    eration on the supraceliac aorta is difficult: once this site has

    been used, reexposure generally is not safe.

    Antegrade bypass Step 1: incision and initial approach 

    Supraceliac aorta–visceral artery bypass is performed through

    an upper midline incision. Self-retaining retractors are very

    helpful.

    Step 2: exposure  The dissection begins with division of the

    gastrohepatic ligament and retraction of the left lobe of the

    liver to the right, followed by incision of the diaphragmaticcrus and exposure of the anterior aspect of the aorta.

    Step 3: choice of graft   In clean cases with no intestinal

    necrosis or perforation, we use woven Dacron grafts. If a

    single-vessel bypass is to be performed, a single limb is cut

    from the bifurcated graft, incorporating a flange of the main

    body of the bifurcated graft for the proximal anastomosis.

    Autologous vein grafts are usually reserved for contaminated

    cases. The femoral vein is an excellent autogenous conduit

    for mesenteric arterial bypass.

    Step 4: anastomosis of graft to supraceliac aorta and visceral

    artery  If the celiac artery alone is to be revascularized, the

    usual procedure is to perform an end-to-side proximal

    anastomosis to the aorta, followed by an end-to-side distal

    anastomosis to the common hepatic artery. If the SMA alone

    is to be revascularized, it is generally necessary to tunnel thegraft beneath the pancreas to the inferior border of the pan-

    creas and then perform an end-to-side anastomosis to the

    SMA at that level [see Figure 5a]. Extreme care must be

    exercised in developing the retropancreatic tunnel. If this area

    appears too narrow or is scarred as a result of previous

    pancreatic inflammation, the graft should be tunneled ante-

    rior to the pancreas to ensure that it is not compressed and

    to avoid causing bleeding from disrupted pancreatic veins.17 

    If a prepancreatic tunnel is required, an autogenous conduit

    should be considered because the graft will be lying adjacent

    to the posterior wall of the stomach. If both the celiac artery

    and the SMA are to be revascularized from the supraceliac

    aorta, a bifurcated prosthetic graft is attached to the suprace-

    liac aorta proximally, with one distal limb anastomosed to the

    hepatic artery and the other to the SMA [see Figure 5b].

    Retrograde bypass In a retrograde bypass, the infrarenal

    aorta or, more commonly, common iliac artery is used as the

    inflow vessel. One clear advantage of this procedure is that

    the approach to the infrarenal aorta is more familiar to most

    surgeons. Another is that dissection and clamping of the infra-

    renal aorta are less risky than dissection and clamping of the

    supraceliac aorta. Yet another is that the surgeon can work

    within a single operative field. Once the self-retaining retrac-

    tor is placed, the operation on the infrarenal aorta and the

    SMA can be performed without further adjustment of the

    retractor. The main disadvantage is the potential for graft

    kinking.

    Step 1: incision and initial approach  Here, too, a midline

    incision and a transperitoneal approach are preferred. The

    transverse mesocolon is retracted upward, and the ligament

    of Treitz is divided.

    Step 2: exposure  After division of the ligament of Treitz,

    the duodenum and the small bowel are retracted to the right.

    The SMA may then be identified arising from beneath the

    inferior border of the pancreas. The retroperitoneum is

    divided distally along the aorta to a point just beyond the

    level of the aortic bifurcation. The distal aorta and both

    common iliac arteries are assessed to allow determination of

    the optimal location for the proximal anastomosis.

    Step 3: choice of graft   As a rule, grafts made of Dacron or

    of ringed, reinforced expanded polytetrafluoroethylene

    (ePTFE) are preferred. Problems may arise when retrograde

    bypasses are performed with autologous vein grafts, in that

    such grafts are prone to kinking when the viscera are replaced.

    When a retrograde vein bypass is performed, the graft may bebrought straight up from the right iliac artery so that it lies

    between the aorta and the duodenum and then anastomosed

    to the posteromedial wall of the SMA.

    Step 4: anastomosis to infrarenal aorta or common iliac artery

    and SMA  Our preference is to use the area near the junction

    of the aorta with the right common iliac artery for the proxi-

    mal anastomosis. (Short grafts originating from the midpor-

    tion of the infrarenal aorta, although commonly described,

    are prone to kinking when the viscera are returned to their

    normal position.) The graft to the SMA is passed cephalad,

    turned anteriorly and inferiorly 180°, and anastomosed to the

    anterior wall of the SMA just beyond the inferior border of

    the pancreas.17 In this manner, a gentle C loop is formed that,

    if placed correctly, keeps the graft from kinking when the

    viscera are restored to their anatomic position after retractorremoval [see Figure 6 ]. The ligament of Treitz and the parietal

    and mesenteric peritoneum are closed over the graft to

    exclude it from the peritoneal cavity.

    Endovascular Techniques

    Endovascular techniques, usually a combination of angio-

    plasty and stent placement, are being used with greater

    frequency for chronic mesenteric ischemia [see Figure 7 ]. By

    2002, endovascular procedures (angioplasty/stent) surpassed

    all surgical procedures performed for chronic mesenteric

    ischemia, with decreased 30-day mortality compared with

    open procedures (4 versus 13%).18 Early reports describing

    the use of percutaneous transluminal angioplasty (PTA) to

    treat visceral atherosclerotic lesions indicated that initial tech-

    nical success rates were as high as 80% but that recurrence

    rates ranged from 20 to 40%.17,19 Recent reports of endovas-cular therapy for chronic mesenteric ischemia showed no

    difference in in-hospital morbidity or mortality or 2-year sur-

    vival. Also, there was no difference in symptomatic (23 versus

    22%) or radiographic (32 versus 37%) recurrence. However,

    radiographic primary patency (58 versus 90%) and primary

    assisted patency (65 versus 96%) were significantly lower

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    5/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 5

    11/11

    in the patients who received endovascular treatment.20 

    Another study with longer follow-up showed 3-year actuarial

    patency of 63%. About 30% of patients required reinterven-

    tion for recurrent symptoms. The median time to reinterven-

    tion for symptom recurrence was 15 months. Because of thishigh rate of restenosis and symptom recurrence, close follow-

    up is mandatory in all patients treated with mesenteric artery

    stents. Most importantly, initial endovascular treatment did

    not preclude any future surgical bypass options.21 These early

    results indicate that an endovascular approach to chronic

    mesenteric ischemia is a viable option in carefully selected

    patients.

    Technical 

    The main technical complication of mesenteric bypass is

    acute graft thrombosis. This event is rare, but when it occurs,

    prompt recognition is essential to prevent intestinal infarc-

    tion. Kinking and compression of the graft are the most

    common causes of this condition. If the retrograde graft is toolong, the redundancy makes it more susceptible to kinking.

    Similarly, if the graft is not positioned so as to form a gentle

    C loop, it is at risk for kinking when the viscera are returned

    to their normal position. An antegrade graft that is too long

    is equally at risk for kinking and occlusion. When an ante-

    grade bypass is tunneled behind the pancreas, an adequate

    amount of space must be present to ensure that the graft

    is not compressed. In general, prosthetic grafts are more

    resistant to kinking and compression than vein grafts are.

    Identification of perioperative graft occlusion is hindered

    by postoperative incisional pain, fluid shifts, fever, and leuko-cytosis, all of which are common in the postoperative period

    and may mask signs of intestinal ischemia. Patients with

    chronic mesenteric ischemia often have symptoms only when

    eating and thus may be asymptomatic in the postoperative

    period until they resume oral feeding. For these reasons,

    we advocate evaluating the graft early in the postoperative

    period with either conventional contrast angiography or CT

    angiography [see Outcome Evaluation, below].

    Additional technical complications may occur as a result

    of clamp placement. Clamping of the supraceliac aorta can

    lead to renal atheroemboli or ischemia. These problems can

    be minimized by using a supraceliac clamp only on an

    angiographically normal aorta.

    Systemic

    Myocardial infarction is the most common cause of mor-tality in patients treated for mesenteric ischemia. Pulmonary

    compromise is also a common systemic complication of mes-

    enteric revascularization. Renal failure after mesenteric revas-

    cularization is more common in patients with preoperative

    renal insufficiency.22  Mortality is markedly increased when

    renal failure occurs postoperatively.22  Postoperative renal

    Figure 5 Arterial bypass: antegrade. Shown is bypass from the supraceliac aorta to the superior mesenteric artery (SMA) alone

    (a) or to the hepatic artery and the SMA (b).39

    a b 

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    6/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 6

    11/11

    insufficiency can be minimized by administering mannitol,

    furosemide, and, possibly, vasodilators intraoperatively.

    Patients who undergo mesenteric revascularization occa-

    sionally experience a profound reperfusion syndrome

    manifested by acidosis, pulmonary compromise, and coagu-

    lopathy. We recommend administering sodium bicarbonate

    (to minimize the effects of metabolic acidosis) and mannitol

    (for its free radical–scavenging properties) before restoring

    intestinal perfusion.

     

    Restoration of pulsatile flow to the small bowel usually

    results in immediate active peristalsis and intestinal edema.

    The technical success of surgical revascularization is assessed

    intraoperatively through visual examination of the intestine

    and continuous-wave Doppler examination of the distal

    mesenteric vasculature and the bowel wall. Doppler signals

    should be detected along the antimesenteric border, and

    pulses should be palpable in the mesentery. Intraoperativeduplex scanning may also be used to visualize anastomotic

    sites directly.23

    Electromagnetic flow measurements can be helpful in

    evaluating the adequacy of mesenteric revascularization. Such

    measurements must be made after all packs and retractors

    have been removed. In most cases, the flow rate through the

    graft should be between 500 and 800 mL/min, but flow rates

    as high as 1,000 mL/min may be recorded.17

    To confirm technical success after mesenteric revascular-

    ization, we advocate routine postoperative imaging of the

    graft. Ideally, this is done early in the postoperative period.

    Catheter-based contrast angiography is optimal for evaluating

    the bypass graft and the distal vasculature, allowing identifi-

    cation of anastomotic stenoses, kinking [see Figure 8a], or,

    in the case of autologous grafts, narrowing caused by valves.

    If a technical defect is discovered, reoperation and correction

    are required to ensure prolonged patency. In the past few

    years, we have started evaluating selected patients periopera-

    tively with CT angiography. This modality is less invasive

    than traditional contrast angiography but still requires

    administration of contrast material and exposure to radiation

    [see Figure 8b].

    Duplex ultrasonography has been used for postoperative

    graft surveillance after mesenteric revascularization.24 

    Although it can be difficult in the early postoperative period

    because of incisional tenderness and postoperative ileus,

    it has proven to be a valuable tool to follow bypass grafts.

    A retrospective study at our institution has defined normal

    duplex ultrasonography–derived velocity characteristics of

    mesenteric artery bypass grafts. The anastomotic and mid-graft peak systolic velocities are not affected by the orienta-

    tion of the graft. Mean peak systemic velocity for most grafts

    is between 140 and 200 cm/s and remains relatively stable on

    repeat examinations. Serial duplex examinations can be used

    to assess the patency of bypass grafts to mesenteric arteries.25 

    We routinely use postoperative duplex scanning to establish

    Figure 6 Arterial bypass: retrograde. Shown is bypass from

    the right common iliac artery to the superior mesenteric

    artery.39 The inset shows a method of graft preparation using

    the main body of a bifurcated graft to provide a flange for the

    proximal anastomosis.

    Figure 7 Computed tomographic angiogram showing a stent

    in a superior mesenteric artery. Mesenteric artery stents are

     being used with increasing frequency as an alternative to

     bypass for treatment for chronic visceral ischemia in

    higher-risk patients.

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    7/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 7

    11/11

    baseline values and to permit comparisons for follow-up

    evaluation of graft patency. If markedly elevated focal peak

    systolic velocities (> 300 cm/s) are recorded, especially if

    they increase on serial examinations, secondary imaging (CT

    or conventional angiography) should be obtained to confirm

    graft stenosis and to possibly plan intervention.

    Procedures for Acute Intestinal Ischemia

     

    As in the evaluation of patients with chronic mesenteric

    ischemia, a high index of suspicion is of primary importance

    in the evaluation of patients with possible acute mesenteric

    ischemia. Most cases of acute intestinal ischemia result either

    from thrombosis of a preexisting stenotic lesion or from

    embolization (most frequently to the SMA).26 Cardiac emboli

    are the most common variety, although tumor emboli27  and

    atheroemboli are seen as well. Atheroemboli generally result

    from iatrogenically induced cholesterol embolization caused

    by aortic catheterization. The prognosis for acute intestinal

    ischemia of embolic origin is more favorable than that for

    acute ischemia of thrombotic origin. Emboli typically lodge

    distally in the SMA distribution; therefore, the proximalintestine is still partially perfused.26 In contrast, thrombotic

    occlusion occurs at the origin of the vessel, resulting in

    complete interruption of midgut perfusion.

    Acute, severe abdominal pain that is out of proportion to

    the physical findings is the classic manifestation and is strongly

    suggestive of intestinal ischemia. The duration of symptoms

    Figure 8 Routine postoperative imaging is performed to confirm technical success after revascularization. (a) A postoperative

    arteriogram shows a iliac artery–superior mesenteric artery (SMA) saphenous vein graft with a kink ( arrow). This problem was

    asymptomatic and was corrected by reoperation on postoperative day 5. (b) A postoperative computed tomographic arteriogram

    shows a retrograde iliac artery–SMA prosthetic graft. C (hook) configuration of distal anastomosis provides antegrade flow into

    the SMA.

    a b 

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    8/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 8

    11/11

    does not appear to correlate with the degree of intestinal

    infarction.28 Peritonitis is initially absent, but vomiting and

    diarrhea may be present, and occult gastric or rectal bleeding

    may be identified in as many as 25% of patients.28

    There are no reliable serum markers for acute intestinal

    ischemia. Leukocytosis, hyperamylasemia, or elevated lactate

    levels may be present, but these findings are insensitive and

    inconsistent. Abdominal radiographs may reveal dilated

    bowel loops and, occasionally, thickened bowel wall, but

    these findings are similarly inconsistent. In theory, duplex

    ultrasonography may be helpful, but in practice, its applica-

    bility is often limited by the gaseous visceral distention

    frequently associated with acute intestinal ischemia.

    Acute intestinal ischemia is a true surgical emergency. Any

    evidence of acute abdomen should result in prompt operative

    intervention. In stable patients suspected of having acute

    mesenteric ischemia, the paradigm for diagnostic workup

    has been slowly shifting toward the use of multidetector CT

    angiography. Multidetector CT angiography uses thinner

    collimation and overlapping data acquisition, which reduces

    the amount of volume averaging and creates higher quality

    volume sets for three-dimensional reconstruction. There

    are several advantages to CT angiography, including near-

    universal 24-hour access to a high-resolution scanner. With

    three-dimensional reconstruction, mesenteric vessels can be

    evaluated for embolus or thrombotic occlusion with accuracy.

    Also, bowel can be evaluated concomitantly to support or

    refute the diagnosis, and other intra-abdominal pathology can

    be evaluated. A prospective study compared preoperative

    radiographic findings with operative findings in 62 patients

    suspected of acute myocardial infarction. Initial radiologist

    interpretation had a sensitivity of 100% and a specificity of

    89%.29 A subsequent study using CT angiography had similar

    results in terms of accuracy.30 Significant limitations include

    the need for proper timing of the contrast to evaluate

    the vasculature and that the modality does not offer any

    therapeutic options.

    The use of preoperative arteriography to diagnose acute

    ischemia is controversial. Delaying treatment to perform

    arteriography could result in further intestinal infarction.Angiography may be considered in patients who have abdom-

    inal pain without any other signs or symptoms of systemic

    illness [see Figure 9 ]. In patients who have rebound tender-

    ness, rigidity, or evidence of toxicity or shock, emergency

    exploration is indicated.

     

    Patients with acute intestinal ischemia who present with

    evidence of toxicity must be resuscitated expeditiously to

    ensure that surgical intervention is not delayed. Once it

    is determined that surgery is indicated, no further delay is

    justified. The patient is placed supine on the operating table,

    and the entire abdomen and both legs are prepared. As in

    operative treatment of chronic intestinal ischemia, the possi-

    bility that autologous vein will be needed for bypass grafting

    must be anticipated.

     

    Intraoperative Considerations

    Mesenteric revascularization and bowel resection

    The goals of surgical therapy are to restore normal pulsatile

    inflow, to ensure that questionably viable bowel is adequately

    perfused, and to resect any clearly nonviable bowel. During

    abdominal exploration, the viability of the intestine and the

    status of the blood flow to the SMA are assessed with an eye

    to determining the appropriate treatment. The surgeon should

    be prepared to perform both intestinal revascularization and

    intestinal resection. Segments of clearly viable bowel are often

    interspersed with segments of marginally viable bowel and

    segments of necrotic bowel. Acutely ischemic bowel that is

    not yet necrotic may appear deceptively normal. Mildly to

    moderately ischemic bowel may exhibit loss of normal sheen,

    absence of peristalsis, and dull-gray discoloration. Other

    objective signs of ischemia are the absence of a palpable pulse

    in the SMA or in its distal branches, the absence of visible

    pulsations in the mesentery, and the absence of flow on

    continuous-wave Doppler examination of the vessels of the

    bowel wall. The small bowel may be deeply cyanotic yet still

    viable. In most cases, bowel resection should not be performed

    until after revascularization.

    The distribution of ischemic changes provides valuable

    information about the cause of the ischemia. SMA thrombo-

    sis often results in ischemia to the entire small bowel, with

    the stomach, the duodenum, and the distal colon spared; in

    severe cases, however, the entire foregut may be ischemic.

    In contrast, ischemia secondary to SMA embolism generally

    spares the stomach, the duodenum, and the proximal jeju-

    num because the emboli tend to lodge at the level of the

    middle colic artery rather than at the origin of the SMA. The

    choice of operation for revascularizing the bowel depends onthe underlying causative condition. Embolectomy is indicated

    for arterial embolism, whereas bypass is indicated for throm-

    botic occlusion.

    Revascularization of the acutely ischemic intestine

    Patients with very advanced intestinal ischemia may have

    Figure 9 Preoperative arteriogram shows embolic occlusion

    of the superior mesenteric artery distal to its origin.

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    9/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 9

    11/11

    obvious widespread bowel necrosis. This situation almost

    invariably proves fatal; thus, revascularization is not likely

    indicated. In many patients, however, substantial portions of

    the bowel are ischemic but not frankly necrotic. Whether

    such bowel segments can be restored to viability cannot be

    accurately predicted. In most instances, therefore, revascular-

    ization should precede resection.

    Restoration of normal flow to the SMA can produce

    remarkable changes in an ischemic bowel. Because these

    changes do not always occur immediately, it is often neces-

    sary to preserve questionably viable portions of the bowel

    initially and then perform a second-look laparotomy within

    12 to 36 hours. If the questionably viable bowel is not in

    significantly better condition at the time of the second-look

    operation, it should be resected. Occasionally, however, even

    a third look is prudent. Revascularized intestine that was

    profoundly ischemic may swell dramatically. Temporary

    abdominal closure with mesh or leaving the abdomen open

    with a temporary closure device may permit tension-free

    abdominal “closure,” prevent abdominal compartment syn-

    drome, and perhaps even improve intestinal perfusion by

    reducing intra-abdominal pressure.

    Superior Mesenteric Artery Embolectomy

    Step 1: incision and initial approach A midline

    incision and transperitoneal approach is used.

    Step 2: exposure of SMA at root of mesentery   The

    SMA is exposed after division of the ligament of Treitz at the

    base of the transverse colon mesentery. The duodenum and

    the small bowel are retracted to the right [see Figure 10 ]. The

    visceral peritoneum is incised above the ligament of Treitz,

    just cephalad to the third portion of the duodenum. The SMA

    should be readily palpable in this location as it crosses over the

    third portion of the duodenum. The dissection is continued to

    obtain sufficient proximal and distal control of the vessel.

    Heparin is administered, and the vessel is clamped proximally

    and distally.

    Step 3: arteriotomy An arteriotomy is then made in theSMA. The incision may be either transverse or longitudinal.

    We prefer to perform a longitudinal arteriotomy if there is any

    possibility that a bypass graft may be needed. The arteriotomy

    should be made approximately 2 to 3 cm distal to the origin of

    the SMA, although alternative placements may be appropriate

    on occasion, depending on the anatomy and the estimated

    location of the occlusion [see Figure 11, a and b].

    Step 4: embolectomy Proximal embolectomy should be

    performed first to ensure adequate inflow. A 3 or 4 French

    balloon catheter is sufficient in most cases. If very good pulsa-

    tile inflow is not achieved after embolectomy, then thrombosis

    of a stenotic lesion is likely to be the underlying cause of the

    acute intestinal ischemia, and a bypass graft should be placed.

    Even when inflow is apparently adequate, a bypass should

    be strongly considered if the proximal SMA is palpably

    abnormal.

    The narrowness and fragility of the distal SMA and its

    branches can make distal embolectomy particularly challeng-

    ing. It is best to use a 2 French embolectomy catheter for this

    procedure. The catheter must be passed gently, without

    undue force.

    Step 5: closure Once all possible thrombus has been

    removed, the arteriotomy is closed. A transverse arteriotomy

    may be closed primarily with interrupted monofilament

    sutures [see Figure 11c]; however, a longitudinal arteriotomy

    frequently must be closed with an autologous vein patch. If

    adequate flow is not restored after the clamps are removed,

    the arteriotomy is used as the distal anastomotic site of a

    bypass graft.

    Superior Mesenteric Artery Bypass

    Patients with SMA thrombosis who are seen early enough

    and who have no intestinal necrosis may undergo SMA

    bypass grafting with a prosthetic conduit. At exploration,

    many of these patients have fluid within the peritoneal cavity.

    This finding is not, in itself, a contraindication to the use

    of a prosthetic graft. However, if the patient has necrotic

    bowel that must be resected or if perforation has occurred,

    a prosthetic graft should not be used. In these situations, an

    autologous vein graft is preferred. A good-quality vein is

    mandatory; if the saphenous vein is inadequate, the femoral

    vein may be used instead.

    The techniques of mesenteric bypass for acute intestinal

    ischemia are identical to those for chronic intestinal ischemia.

    Because these patients are often acutely ill, it is vital toperform the operation rapidly and efficiently. In the acute

    setting, bypass to the SMA alone is strongly preferred [see

     Figure 12]. As a rule, a retrograde approach, using the infra-

    renal aorta or a common iliac artery for inflow, is best; the

    supraceliac aorta is used for inflow only if the infrarenal

    vessels are unsuitable for this purpose. Even highly calcified

    iliac arteries can be used for inflow provided that there is no

    significant pressure gradient and that the surgeon is familiar

    with intraluminal balloon occlusion techniques for proximal

    and distal control.

    Hybrid Technique: Retrograde Open Mesenteric Stenting 

    Recently, a hybrid technique has been described that

    combines the attributes of both endovascular and open

    procedures. It allows for both endovascular treatment of mes-

    enteric vessels and thorough assessment of bowel viability.

    Initial results show a 100% initial success and a lower

    in-hospital mortality rate of 17% compared with surgical

    bypass or endovascular treatment.31,32

    Step 1: Incision and exposure A patient suspected of

    acute myocardial infarction is brought directly to the operat-

    ing room with ongoing resuscitation. The left arm is abducted

    and prepared along with standard preparation for potential

    brachial access. Once the diagnosis is confirmed, initial mid-

    line exploration and control of the infracolic SMA is obtained

    as described for an SMA embolectomy procedure.

    Step 2: Patch angioplasty and cannulation of infra-

    colic SMA Once exposure and control of infracolic SMA

    are obtained, the patient is fully heparinized to activatedclotting time of more than 300 seconds. The artery is incised

    longitudinally, and a local thromboendarterectomy with patch

    angioplasty is performed. Either bovine pericardium or saphe-

    nous vein can be used for the patch. A purse-string suture is

    placed in the patch, through which a 6 French sheath is placed

    into the SMA in retrograde fashion through the distal end of

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    10/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 10

    11/11

    SMA

    DividedLigament of Treitz

    IMA

    Figure 10 Superior mesenteric

    artery (SMA) embolectomy.

    Exposure of the infrarenal aorta,

    proximal right common iliac

    artery, and proximal SMA is

    achieved by intestinal retraction

    and division of the posterior

    peritoneum, ligament of Treitz,

    and base of small bowel

    mesentery.40 IMA = inferior

    mesenteric artery.

    b    c 

    Figure 11 Superior mesenteric artery (SMA) embolectomy.

    (a) The location of embolus within the SMA is identified.

    (b) Transverse (as shown) or longitudinal arteriotomy is

    performed, and the embolus is extracted with a balloon

    catheter. (c) Arteriotomy is closed. Primary closure (as

    shown) suffices for transverse arteriotomy, but a vein patch is

    usually required for closure of longitudinal arteriotomy.40

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    11/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 11

    11/11

    the patch. This allows for placement and removal of the sheath

    without clamping of the vessel. Once the sheath is in place,

    all metal retractors are removed. The sheath should be long

    enough to allow the surgeon to work out of the wound and

    away from the image intensifier.

    Step 3: Crossing the lesion with a guidewire Initially,

    hand-injected, retrograde, lateral angiography is performed to

    delineate the lesion. This angiogram is used as a road map

    to cross the lesion with a 0.035-inch glidewire. This is then

    catheter exchanged for a lower profile 0.018- or 0.014-inch

    platform.

    Step 4: Predilatation and stent deployment The

    lesion is then predilated with a 2 or 3 mm angioplasty balloon.

    A 5 to 7 mm low-profile balloon-expandable stent is deployedin a retrograde fashion. The proximal-most stent is allowed

    to protrude 1 to 2 mm into the aortic lumen. More than one

    stent may be required to cross the entire length of the lesion.

    Completion angiography in the anteroposterior and lateral

    projections and pressure measurements are performed across

    the lesion.

    Step 5: Sheath removal and assessment of bowel

    viability After completion angiography is performed, the

    sheath is removed and the puncture site in the patch is

    repaired. The entire bowel is thoroughly examined, and

    any grossly necrotic bowel is expeditiously resected. Final

    assessment and reanastomosis are usually delayed for 24 to

    48 hours.

    Endovascular Techniques

    Purely endovascular techniques have a limited role in the

    treatment of acute mesenteric ischemia as they do not offer

    assessment of ischemic bowel. General surgical principles of

    thorough abdominal exploration, along with sepsis control

    and routine second-look operations, must be honored in all

    patients with acute mesenteric ischemia to optimize favorable

    outcomes. It would seem reasonable that endovasculartherapies might come to play a role in the treatment of acute

    intestinal ischemia, given that preoperative angiography is

    usually feasible in stable patients. Several groups have reported

    treating acute arterial embolism with intra-arterial thrombol-

    ysis33,34; others have reported treating acute embolism, as well

    as thrombotic occlusion, with PTA.35,36  Although a degree

    a b 

    Figure 12 Superior mesenteric artery (SMA) bypass. (a) Iliac artery–SMA bypass with a prosthetic graft is suitable for cases in

    which SMA thrombosis produces ischemic but salvageable bowel. (b) Iliac artery–SMA bypass with a saphenous vein is suitable

    for cases in which some segments of necrotic or perforated bowel must be resected.40

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    12/13

    MESENTERIC REVASCULARIZATION PROCEDURES — 12

    10/11

    of anecdotal success with these techniques has been achieved

    in selected cases, it should be kept in mind that reliance on

    endovascular therapy alone for presumed acute intestinal

    ischemia runs the risk of missing bowel necrosis. After endo-

    vascular therapy, frequent clinical reevaluation is necessary

    to identify patients with persistent intestinal ischemia.

    Abdominal exploration should be very strongly considered

    in most cases, even if the angiographic result of the endovas-

    cular procedure is good.

    Occasionally, patients present with emboli that have lodged

    in the small arterial branches of the SMA. These vessels are

    often too small to allow the passage of embolectomy cathe-

    ters, and bypass beyond the point of obstruction frequently is

    not possible. In these situations, resection of marginally viable

    bowel is the best option.

    As noted (see above), avoidance of graft kinking is crucial

    for preventing early graft failure. Graft failure can have an

    even greater adverse effect on bowel viability in the setting

    of acute ischemia than in the setting of chronic intestinal

    ischemia.

    Recovery after revascularization is often prolonged.

    Early and prolonged parenteral nutrition may be necessaryin patients with extensive bowel infarction. Only rarely,

    however, is lifelong parenteral nutrition required.

     

    The techniques employed to evaluate the success of mes-

    enteric revascularization for acute ischemia include clinical

    inspection, continuous-wave Doppler ultrasonography,

    and intravenous (IV) administration of fluorescein. Clinical

    inspection entails visual assessment of pulsatile flow in the

    mesenteric arcades, peristalsis, bleeding from cut surfaces,

    and, of course, color. In one study, clinical parameters

    were found to be 82% sensitive and 91% specific for bowel

    viability.37

    We routinely use a sterile continuous-wave Doppler ultra-

    sonography to evaluate pulsatile flow on the bowel surface.Grossly discolored bowel with no Doppler signal after a

    period of observation should be resected; marginal bowel

    with no Doppler signal is an indication for second-look

    laparotomy.

    With the fluorescein fluorescence method, 10 to 15 mg/kg

    of fluorescein is injected intravenously, and the intestine is

    inspected with a Wood lamp. A complete absence of fluores-

    cence is diagnostic of nonviability; rapid, confluent, bright

    fluorescence indicates viability. There is, however, a large

    gray area between these two extremes in which interpretation

    is subjective. In one study, the IV fluorescein method was

    found to be 100% sensitive and specific for detecting non-

    viable bowel.38 The disadvantages of this technique are that

    it requires special equipment and that it exposes the critically

    ill patient to the risk of an adverse reaction to the dye.Other assessment methods (e.g., surface oximetry, infrared

    photoplethysmography, and laser Doppler velocimetry) are

    available, but at present, they are mostly experimental and

    are not in general use for evaluation of bowel viability in a

    clinical setting.

     Financial Disclosures: None Reported

     References

      1. Dunphy JE. Abdominal pain of vascular

    origin. Am J Med Sci 1936;192:109.

     2. Moneta GL. Diagnosis of intestinal ischemia.

    In: Rutherford RB, editor. Vascular surgery.

    Philadelphia: WB Saunders; 2000. p. 1501.

      3. Moneta GL, Yeager RA, Dalman R, et al.

    Duplex ultrasound criteria for diagnosis of

    splanchnic artery stenosis or occlusion. J Vasc

    Surg 1991;14:511.

      4. Nicholls SC, Kohler TR, Martin RL, et al.

    Use of hemodynamic parameters in the diag-

    nosis of mesenteric insufficiency. J Vasc Surg

    1986;3:507.

      5. Moneta GL, Lee RW, Yeager RA, et al.

    Mesenteric duplex scanning: a blinded pro-

    spective study. J Vasc Surg 1993;17:79–84.

      6. Cademartiri F, Raaijmakers RH, Kuiper JW,

    et al. Multi-detector row CT angiography

    in patients with abdominal angina. Radio-

    graphics 2004;24:969–84.

    7. Wildermuth S, Leschka S, Alkadhi H,

    Marincek B. Multislice CT in the pre- and

    postinterventional evaluation of mesenteric

    perfusion. Eur Radiol 2005;15:1203–10.

    8. Shih MC, Hagspiel KD. CTA and MRA in

    mesenteric ischemia: part 1, role in diagnosis

    and differential diagnosis. AJR Am J Roent-

    genol 2007;188:452–61.

    9. Shih MC, Angle JF, Leung DA, et al. CTA

    and MRA in mesenteric ischemia: part 2,

    normal findings and complications after sur-

    gical and endovascular treatment. AJR Am J

    Roentgenol 2007;188:462–71.

    10. Shaw RS, Maynard EP III. Acute and

    chronic thrombosis of the mesenteric arteries

    associated with malabsorption: a report of

    two cases successfully treated by thromboen-

    darterectomy. N Engl J Med 1958;258:874.

    11. Hansen HJB. Abdominal angina: results ofarterial reconstruction in 12 patients. ActaChir Scand 1976;142:319.

    12. Stoney RJ, Ehrenfeld WK, Wylie EJ. Revas-

    cularization methods in chronic visceralischemia. Ann Surg 1977;186:468.

    13. McAfee MK, Cherry KJ, Naessens JM, et al.Influence of complete revascularizationon chronic mesenteric ischemia. Am J Surg1992;164:220.

    14. Foley MI, Moneta GL, Abou-Zamzam AM,et al. Revascularization of the superior mes-enteric artery alone for treatment of intestinalischemia. J Vasc Surg 2000;32:37.

    15. Park WM, Cherry KJ, Chua HK, et al. Cur-rent results of open revascularization forchronic mesenteric ischemia: a standard forcomparison. J Vasc Surg 2002;35:853.

    16. Murray SP, Ramos TK, Stoney RJ. Surgeryof the celiac and mesenteric arteries. In:Ascher E, editor. Haimovici’s vascular sur-

    gery. Malden (MA): Blackwell Publishing;2004. p. 861.

    17. Taylor LM, Moneta GL, Porter JM.Treatment of chronic visceral ischemia. In:

    Rutherford RB, editor. Vascular surgery.Philadelphia: WB Saunders; 2000. p. 1532.18. Schemerhorn ML, Giles KA, Hamdan AD,

    et al. Mesenteric revascularization: manage-ment and outcomes in United States 1988– 2006. J Vasc Surg 2009;50:341–8.

    19. Odurny A, Sniderman KW, Colapinto RF.Intestinal angina: percutaneous transluminal

    angioplasty of the celiac and superior mesen-

    teric arteries. Radiology 1988;167:59.

    20. Atkins MD, Kwolek CJ, LaMuraglia GM,

    et al. Surgical revascularization versus

    endovascular therapy for chronic mesenteric

    ischemia: a comparative experience. J Vasc

    Surg 2007;45:1162–71.

    21. Peck MA, Conrad MF, Kwolek CJ, et al.

    Intermediate-term outcomes of endovascular

    treatment for symptomatic chronic mesen-

    teric ischemia. Vasc Surg 2010;51:140– 

    7.e1–2.

    22. Mateo RB, O’Hara PJ, Hertzer NR, et al.

    Elective surgical treatment of symptomatic

    chronic mesenteric occlusive disease: early

    results and late outcomes. J Vasc Surg

    1999;29:821.

    23. Leke MA, Hood DB, Rowe VL, et al. Techni-

    cal consideration in the management of

    chronic mesenteric ischemia. Am Surg 2002;

    68:1088.

    24. Nicoloff AD, Williamson WK, Moneta GL,

    et al. Duplex ultrasonography in evaluation of

    splanchnic artery stenosis. Surg Clin North

    Am 1997;77:339.

    25. Liem TK, Segall JA, Wei W, et al. Duplex

    scan characteristics of bypass grafts to mesen-

    teric arteries. J Vasc Surg 2007;45:922–7.

    26. Taylor LM, Moneta GL, Porter JM.Treatment of acute intestinal ischemia caused

    by arterial occlusions. In: Rutherford RB,

    editor. Vascular surgery. Philadelphia: WB

    Saunders; 2000. p. 1512.

    27. Low DE, Frenkel VJ, Manley PN, et al.

    Embolic mesenteric infarction: a unique

    initial manifestation of renal cell carcinoma.

    Surgery 1989;106:925.

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific

  • 8/16/2019 Part06 Ch14 Copy

    13/13

     MESENTERIC REVASCULARIZATION PROCEDURES — 13

    10/11

    28. Ottinger LW. The surgical management of

    acute occlusion of the superior mesenteric

    artery. Ann Surg 1978;188:72L.

    29. Kirkpatrick ID, Kroeker MA, Greenberg

    HM. Biphasic CT with mesenteric CT angi-

    ography in the evaluation of acute mesenteric

    ischemia: initial experience. Radiology 2003;

    229:91–8.

    30. Aschoff AJ, Stuber G, Becker BW, et al. Eval-

    uation of acute mesenteric ischemia: accuracy

    of biphasic mesenteric multi-detector CTangiography. Abdom Imaging 2009;34:

    345–57.

    31. Milner R, Woo EY, Carpenter JP. Superior

    mesenteric artery angioplasty and stenting via

    a retrograde approach in a patient with bowel

    ischemia—a case report. Vasc Endovasc Surg

    2004;38:89–91.

    32. Wyers MC, Powell RJ, Nolan BW, Cro-

    nenwett JL. Retrograde mesenteric stenting

    during laparotomy for acute occlusive mesen-

    teric ischemia. J Vasc Surg 2007;45:269–75.33. Calin GA, Calin S, Ionescu R, et al. Success-

    ful local fibrinolytic treatment and balloonangioplasty in superior mesenteric arterialembolism: a case report and literature review.

    Hepatogastroenterology 2003;50:732.34. Michel C, Laffy P, Leblanc G, et al.

    Intra-arterial fibrinolytic therapy for acutemesenteric ischemia. J Radiol 2001;82:55.

    35. Yilmaz S, Gurkan A, Erdogan O, et al.

    Endovascular treatment of an acute superiormesenteric artery occlusion following failedsurgical embolectomy. J Endovasc Ther2003;10:386.

    36. Brountzos EN, Critselis A, Magoulas D, et al.

    Emergency endovascular treatment of a supe-rior mesenteric artery occlusion. CardiovascIntervent Radiol 2001;24:57.

    37. Bulkley GB, Zuidema GD, Hamilton SR,et al. Intraoperative determination of small

    bowel viability following ischemic injury:

    a prospective, controlled trial of two adjuvant

    methods (Doppler and fluorescein) compared

    with standard clinical judgment. Ann Surg

    1981;193:628.

    38. Carter MS, Fantini GA, Sammartano RJ,

    et al. Qualitative and quantitative fluorescein

    fluorescence in determining intestinal viabi-

    lity. Am J Surg 1984;147:117.

    39. Taylor LM Jr, Porter JM. Treatment of

    chronic intestinal ischemia. Semin Vasc Surg1990;3:186.

    40. Kazmers A. Operative management of acute

    mesenteric ischemia. Ann Vasc Surg 1998;

    12:187.

     Acknowledgment 

    Figures 5, 6, 10, 11, and 12 Alice Y. Chen

    © 2011 Decker Intellectual Properties

    VASCULAR SYSTEM

    American SurgeryScientific